A clinical-stage biotechnology company developing long-acting biologics for severe inflammatory respiratory diseases. Its pipeline is anchored by verekitug, a monoclonal antibody that antagonizes the thymic stromal lymphopoietin (TSLP) receptor.
A clinical-stage biotechnology company developing long-acting biologics for severe inflammatory respiratory diseases. Its pipeline is anchored by verekitug, a monoclonal antibody that antagonizes the thymic stromal lymphopoietin (TSLP) receptor.
